Transdermal Opioids and the Quality of Life of the Cancer Patient: A Systematic Literature Review.
Patricia Santos ReisDurval Campos KraycheteEmilie de Magalhães PedreiraEduardo Silva Reis BarretoCésar Romero Antunes JúniorVinicius Borges AlencarAnna Karla do Nascimento SouzaLiliane Elze Falcão Lins-KustererLiana Maria Torres de Araujo AziPublished in: The Annals of pharmacotherapy (2024)
Transdermal therapy was suggested to have several advantages over oral opioid therapy in enhancing cancer patients' QoL. These benefits span various dimensions, including pain management, physical functioning, mental health, vitality, overall patient improvement, anger/aversion, strength/activity, general QoL, cognitive and emotional functions, fatigue, and insomnia.